FTI
78
-3
CSX
68
3
MU
32
-6
SRE
66
-3
PSX
47
3
SWKS
33
-10
SYF
93
-2
DG
12
2
EW
32
3
STX
52
-4
NSC
64
2
DUK
50
-2
RRC
60
-3
FRT
48
2
QCOM
55
-2
IFF
53
2
CTSH
65
-3
LNC
45
-4
CI
52
-7
SHW
70
2
FTI
78
-3
CSX
68
3
MU
32
-6
SRE
66
-3
PSX
47
3
SWKS
33
-10
SYF
93
-2
DG
12
2
EW
32
3
STX
52
-4
NSC
64
2
DUK
50
-2
RRC
60
-3
FRT
48
2
QCOM
55
-2
IFF
53
2
CTSH
65
-3
LNC
45
-4
CI
52
-7
SHW
70
2
Financhill
Back

Ovid Therapeutics Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Buy
63

OVID
Ovid Therapeutics

Last Price:
1.17
Seasonality Move:
-0.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Ovid Therapeutics Price Quote

$1.17
-0.06 (-4.49%)
(Updated: November 14, 2024 at 12:25 PM ET)

Ovid Therapeutics Key Stats

Buy
63
Ovid Therapeutics (OVID) is a Buy
Day range:
$1.11 - $1.27
52-week range:
$0.68 - $4.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
154.70
P/B ratio:
0.99%
Volume:
385.1K
Avg. volume:
165.9K
1-year change:
-62.88%
Market cap:
$88M
Revenue:
$391.7K
EPS:
$-0.43

How Much Does Ovid Therapeutics Make?

Is Ovid Therapeutics Growing As A Company?

  • What Is Ovid Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.25%
  • What Is Ovid Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ovid Therapeutics Stock Price Performance

What Is Ovid Therapeutics 52-Week High & Low?

Ovid Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ovid Therapeutics?

  • How Much Debt Does Ovid Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Ovid Therapeutics Have?
    Cash and short term investments quarterly total is $77M
  • What Is Ovid Therapeutics’s Book Value Per Share?
    Book value per share is 1.25

Is Ovid Therapeutics Cash Flow Positive?

  • What Is OVID Cash Flow From Operations?
    Cash flow from operations (TTM) is -$52.9M
  • What Is Ovid Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $30.8M
  • What Is Ovid Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$19.9M

Ovid Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    OVID return on invested capital is -31.85%
  • What Is Ovid Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -22.71%
  • What Is OVID Return On Equity?
    ROE is a measure of profitability and is -31.85%

Ovid Therapeutics Earnings Date & Stock Price

Ovid Therapeutics Competitors

  • Who Are Ovid Therapeutics's Competitors?
    Below is a list of companies who compete with Ovid Therapeutics or are related in some way:
    • iBio Inc (IBIO)
    • Eli Lilly and Co (LLY)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Ovid Therapeutics Dividend Yield

Ovid Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 11.89%
Revenue: 125.33% 147.14%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 3.26
Upside from Last Price: 166.12%

Major Shareholders

  • How many OVID shares are owned by institutional investors?
    48.9M OVID shares are owned by institutional investors
  • How many OVID shares are owned by insiders?
    8.8M OVID shares are owned by insiders